Trials / Completed
CompletedNCT03030963
Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery
Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Ventilator mode change was associated with decrease in blood loss during posterior lumbar interbody fusion (PLIF) due to decrease in the peak inspiratory pressure (PIP). The purpose of this study was to determine the effect of equal ratio ventilation (ERV), which sets the I:E ratio of the ventilator to 1:1 during volume controlled ventilaiton, on surgical blood loss during PLIF. Investigators hypothesized that ERV would decrease surgical blood loss due to decrease in the PIP.
Detailed description
After anesthesia, patients will receive ventilator settings according to theri group. The CVP will be measured before and after the prone position to ensure the proper positioning. Airway pressures including peak inspiratory pressure, mean/plateau airway pressure, arterial blood gas analysis data, hct, lactate, body temperature, mean arterial pressure, cardiac index. Recodings will be done 5min afte the induction, 5 min after the prone positioning, sikin suture, and 5min after supine position. Amount of bleeding, coagulation profile and Hct will be recorded 72 hrs after the surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Equal ratio ventilation(ERV) | Set the inspiratory to expiratory ratio 1:1 during mechanical ventilation |
| OTHER | I:E Ratio "1:2 | Set the inspiratory to expiratory ratio 1:2 during mechanical ventilation |
Timeline
- Start date
- 2017-03-06
- Primary completion
- 2018-03-04
- Completion
- 2018-03-31
- First posted
- 2017-01-25
- Last updated
- 2018-08-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03030963. Inclusion in this directory is not an endorsement.